Organization
University of Cincinnati
36 clinical trials
Clinical trial
Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)Status: Recruiting, Estimated PCD: 2025-07-30
Clinical trial
Phase 1b/II Trial Combining PD1 Inhibition (Pembrolizumab) and Cesium 131 Brachytherapy With Salvage Surgery to Enhance Immunogenicity and Improve Local Control in Head and Neck CancerStatus: Active (not recruiting), Estimated PCD: 2025-02-04
Clinical trial
REDEL Trial: Reduced Elective Nodal Dose for Anal Cancer Toxicity MitigationStatus: Recruiting, Estimated PCD: 2026-08-14
Clinical trial
Mechanism of Antidepressant-Related Dysfunctional Arousal in High-Risk YouthStatus: Completed, Estimated PCD: 2022-07-01
Clinical trial
Blood Pressure After Endovascular Stroke Therapy-II: A Randomized TrialStatus: Completed, Estimated PCD: 2022-07-01
Clinical trial
An Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma: A Phase II TrialStatus: Recruiting, Estimated PCD: 2024-05-01
Clinical trial
Treating Bacterial Overgrowth in Parkinson's DiseaseStatus: Completed, Estimated PCD: 2017-08-01
Clinical trial
A Phase II Trial to Evaluate the Use of Trental and Vitamin E for Prophylaxis of Radiation NecrosisStatus: Completed, Estimated PCD: 2017-02-01
Clinical trial
Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease TrialStatus: Recruiting, Estimated PCD: 2025-06-30
Clinical trial
Respiratory Mechanics Following Brain Injury: The Role of Inhaled Nitric OxideStatus: Completed, Estimated PCD: 2023-12-28
Clinical trial
Multicenter International Lymphangioleiomyomatosis Efficacy and Safety of Sirolimus TrialStatus: Completed, Estimated PCD: 2010-09-01
Clinical trial
A Phase 0/1 Pharmacokinetic and Pharmacodynamics and Safety and Tolerability Study of Letrozole in Combination With Standard Therapy in Recurrent High Grade GliomasStatus: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
Exploratory Open-Label Study of Effects on Responsive Neurostimulator Activity After Intranasal Administration of Single Dose of Valtoco® to People With EpilepsyStatus: Completed, Estimated PCD: 2022-11-10
Clinical trial
Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia (The SCOPE Trial)Status: Completed, Estimated PCD: 2020-07-15
Clinical trial
Minocycline In Neurocognitive Outcomes - Sickle Cell DiseaseStatus: Not yet recruiting, Estimated PCD: 2025-12-01
Clinical trial
Phase II Trial of Post-operative or Definitive Concurrent Radiation and Cetuximab for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and NeckStatus: Completed, Estimated PCD: 2022-01-19
Clinical trial
Feasibility of PET/CT to Detect the Oral/Pulmonary Distribution of Nicotine Following E-cigarette UseStatus: Active (not recruiting), Estimated PCD: 2024-12-31
Clinical trial
Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)Status: Recruiting, Estimated PCD: 2024-07-30
Clinical trial
Acute, Double-blind, Adaptively Randomized Treatment With Duloxetine or Escitalopram, Followed by Open-label Naturalistic Follow-up.Status: Recruiting, Estimated PCD: 2024-07-01
Clinical trial
T-Cell Reinfusion After Interfering With Lymphocyte Binding Location of AIDS Virus Through Zinc-finger-nuclease Elimination of CCR5 Receptors: The TRAILBLAZER StudyStatus: Completed, Estimated PCD: 2024-01-31
Clinical trial
Trial of Letrozole in LymphangioleiomyomatosisStatus: Completed, Estimated PCD: 2014-09-01
Clinical trial
Extracellular Vesicles as Predictors of Antidepressant Outcomes in Pediatric Anxiety (EV-SOPRANO)Status: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
Pharmacogenetically-guided Escitalopram Treatment for Pediatric Anxiety: Aiming to Improve Safety and Efficacy (PrEcISE)Status: Recruiting, Estimated PCD: 2025-06-30
Clinical trial
Improving Neurotrauma by Depolarization Inhibition With Combination Therapy (INDICT): a Phase 2 Randomized, Feasibility TrialStatus: Recruiting, Estimated PCD: 2026-04-01
Clinical trial
The Impact of Topical Tranexamic Acid on Pre- and Post-operative Hemoglobin / Hematocrit in Isolated Operative Posterior Wall Acetabular Fractures: a Prospective, Randomized, Double-blinded, Multicenter StudyStatus: Recruiting, Estimated PCD: 2025-08-30
Clinical trial
Neuroimaging Study of Risk Factors for Adolescent Bipolar DisorderStatus: Completed, Estimated PCD: 2022-08-01
Clinical trial
Randomized Trial Comparing Interscalene Nerve Block to Liposomal Bupivacaine For Pain Management Following Reverse Total Shoulder Arthroplasty (RTSA)Status: Completed, Estimated PCD: 2022-11-01
Clinical trial
Epidural Steroid Injection With Supplemental Oral Eplerenone for Low Back Pain: A Prospective, Double Blind Randomized TrialStatus: Withdrawn, Estimated PCD: 2025-12-01
Clinical trial
Multicenter International Durability and Safety of Sirolimus in LAM Trial (MIDAS)Status: Recruiting, Estimated PCD: 2024-07-31
Clinical trial
Pilot and Randomized, Controlled Studies to Assess Stool Frequency of COVID + Patients Treated With Oral Bismuth Subsalicylate (Pepto-Bismol): SABER-C and Lite-SABER-C (Specific Administration of Bismuth for Early Recovery of COVID-19)Status: Completed, Estimated PCD: 2021-08-15
Clinical trial
Resveratrol and Sirolimus in Lymphangioleiomyomatosis Trial (RESULT)Status: Completed, Estimated PCD: 2022-10-15
Clinical trial
Phase II Study of the Efficacy of Amifostine (Ethyol) in Reducing the Incidence and Severity of Oxaliplatin-Induced Neuropathy in Patients With Colorectal CancerStatus: Terminated, Estimated PCD: 2010-01-13
Clinical trial
Imaging of Bladder Cancer Using Clinical 3 Tesla MRI and EX-VIVO Ultra-High-Field MRI.Status: Active (not recruiting), Estimated PCD: 2024-12-31
Clinical trial
Efficacy of Hematoma Block on Postoperative Pain After Femoral Intramedullary Rodding: A Randomized TrialStatus: Completed, Estimated PCD: 2023-02-07
Clinical trial
A Prospective, Randomized, Controlled, Double-Blinded, Multi-Center, Phase 1/2b Study to Evaluate the Safety and Efficacy of AM3101 to Augment Meniscal HealingStatus: Recruiting, Estimated PCD: 2024-01-01
Clinical trial
On the Regulation of Hepatic Glucose Metabolism During Insulin-induced HypoglycemiaStatus: Active (not recruiting), Estimated PCD: 2027-06-01